piracetam has been researched along with Neurodegenerative Diseases in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Piracetam treatment offered significant protection against LPS induced oxidative and inflammatory parameters and inhibited astrocytes activation." | 1.48 | New therapeutic activity of metabolic enhancer piracetam in treatment of neurodegenerative disease: Participation of caspase independent death factors, oxidative stress, inflammatory responses and apoptosis. ( Biswas, J; Chaturvedi, S; Gupta, P; Gupta, S; Joshi, N; Singh, A; Singh, S; Sivarama Raju, K; Tiwari, S; Verma, DK; Wahajuddin, M, 2018) |
| "Levetiracetam (LEV) has been shown to suppress myoclonus of various origins." | 1.35 | Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases. ( Barsi, P; Farsang, M; Györke, T; Kamondi, A; Kovács, T; Szirmai, I; Vitaszil, E, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manetti, D | 1 |
| Martini, E | 1 |
| Ghelardini, C | 1 |
| Dei, S | 1 |
| Galeotti, N | 1 |
| Guandalini, L | 1 |
| Romanelli, MN | 1 |
| Scapecchi, S | 1 |
| Teodori, E | 1 |
| Bartolini, A | 1 |
| Gualtieri, F | 1 |
| Verma, DK | 1 |
| Gupta, S | 1 |
| Biswas, J | 1 |
| Joshi, N | 1 |
| Singh, A | 1 |
| Gupta, P | 1 |
| Tiwari, S | 1 |
| Sivarama Raju, K | 1 |
| Chaturvedi, S | 1 |
| Wahajuddin, M | 1 |
| Singh, S | 1 |
| Kovács, T | 1 |
| Farsang, M | 1 |
| Vitaszil, E | 1 |
| Barsi, P | 1 |
| Györke, T | 1 |
| Szirmai, I | 1 |
| Kamondi, A | 1 |
3 other studies available for piracetam and Neurodegenerative Diseases
| Article | Year |
|---|---|
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs.
Topics: Amnesia; Animals; Avoidance Learning; Chemical Phenomena; Chemistry, Physical; Cognition; Dose-Respo | 2003 |
New therapeutic activity of metabolic enhancer piracetam in treatment of neurodegenerative disease: Participation of caspase independent death factors, oxidative stress, inflammatory responses and apoptosis.
Topics: Animals; Apoptosis; Apoptosis Inducing Factor; Brain; Disease Models, Animal; Endodeoxyribonucleases | 2018 |
Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases.
Topics: Anticonvulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Myoclonus; Neurodegenerative Dise | 2009 |